Related Experiment Videos
Disseminated intravascular coagulation syndromes
1Regional Cancer and Blood Disease Center of Kern, Bakersfield, CA.
Insights
Disseminated intravascular coagulation (DIC) involves complex hemostasis system interactions. Understanding these pathophysiological links is crucial for diagnosing and managing DIC, though treatment remains individualized and controversial.
Area of Science:
- Hematology
- Pathophysiology
- Clinical Medicine
Background:
- Disseminated intravascular coagulation (DIC) presents a complex clinical challenge.
- Understanding the intricate interrelationships within the hemostasis system is key to managing DIC.
- Confusing clinical and laboratory findings are common in patients with DIC.
Purpose of the Study:
- To present current concepts on the etiology, pathophysiology, diagnosis, and management of DIC.
- To highlight the importance of understanding pathophysiological interrelationships in DIC.
- To discuss the controversies and individualized nature of DIC therapy.
Main Methods:
- Review of current concepts and literature on disseminated intravascular coagulation.
- Analysis of the interrelationship within the hemostasis system.
- Discussion of diagnostic and management strategies for DIC.
Main Results:
- Clinicians and scientists must understand pathophysiological interrelationships to interpret DIC findings.
- Therapeutic decisions in DIC are often controversial and require individualized approaches.
- Many organ-specific syndromes share pathophysiology with DIC but are recognized as distinct entities.
Conclusions:
- A clear understanding of hemostasis system interrelationships is vital for DIC management.
- Individualized therapy is essential, considering patient-specific factors and DIC characteristics.
- DIC shares pathophysiology with various organ-specific syndromes, necessitating careful differentiation.
Abstract:
Current concepts of the etiology, pathophysiology, diagnosis and management of fulminant as well as low-grade disseminated intravascular coagulation have been presented. Considerable attention has been devoted to interrelationship within the hemostasis system. Only by clearly understanding these pathophysiological interrelationships can the clinician and laboratory scientists appreciate the divergent and wide spectrum of often confusing clinical and laboratory findings in patients with disseminated intravascular coagulation. Many therapeutic decisions to be made in these patients are controversial and will remain so until more series of patients are published about specific therapeutic modalities and survival patterns. Also, therapy must be highly individualized depending on the nature of DIC, age, etiology of DIC, site and severity of hemorrhage or thrombosis and hemodynamic and other clinical parameters. Many syndromes which are organ specific share common pathophysiology with disseminated intravascular coagulation but are typically identified as an independent disease entity, such as hemolytic uremic syndrome, adult shock lung syndrome, eclampsia, and many other isolated "organ-specific" disorders. Many of these similar disorders, some systemic and some organ specific or multi-organ specific are listed in Table 8.